-
-
-
-
-
-
-
The Lovesac Company Reports Fourth Quarter and Fiscal 2026 Financial Results
-
-
-
-
-
-
-
Cannara Biotech Delivers Record Fiscal 2025 Revenue and Profitability, Achieves First Year of Positive Retained Earnings
-
-
-
-
-
-
-
The Lovesac Company issues Notice of Settlement of Shareholder Derivative Actions
-
-
-
-
-
-
-
The Lovesac Company Reports Fourth Quarter And Fiscal 2025 Financial Results
-
-
-
-
-
-
-
The Lovesac Company Announces Third Quarter Fiscal 2025 Conference Call Date
-
-
-
-
-
-
-
The Lovesac Company Reports First Quarter Fiscal 2025 Financial Results
-
-
-
-
-
-
-
Cannara Biotech Announces Record-Breaking Q1 2024 Results: Continued Robust Growth and Market Expansion
-
1,198,739 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

